Neonatal enterovirus infections in Italy
Part of Infections clinical trials.
This study looks at enterovirus infections in newborn babies admitted to intensive care, focusing on one type called echovirus 11. It aims to better understand the virus and how it affects babies to improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a newborn (up to 28 days old) admitted to a neonatal intensive care unit (NICU)
- A nasal swab sample was taken from your baby and enough is left for this study (at least 1 mL)
- Your baby is being treated at a participating hospital in Italy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how RSV (a common virus that can affect breathing) leads to illness in young children who come to the doctor with ear infections and/or breathing symptoms. It may help doctors better understand the “burden” RSV causes in both home/outpatient and hospital settings.
This trial looks at how well the drug nirsevimab works for babies hospitalized with RSV bronchiolitis. It also studies the body's immune response and the baby's environment. The goal is to see if nirsevimab can help infants recover from this serious lung infection.
This study follows babies under 12 months old who are hospitalized with bronchiolitis to understand their treatment and outcomes. It includes tracking RSV testing and a new immunization called nirsevimab, which may help protect against severe illness.
This study looks at how well the new nirsevimab vaccine works against bronchiolitis in babies. If your infant has their first bout of bronchiolitis and gets a nose swab, they may be able to help researchers understand how the virus spreads and how to better protect other babies.
This study tracks young children under 5 who arrive at certain hospital emergency departments in Türkiye with RSV (a virus that causes colds and breathing trouble). By watching their symptoms and care, doctors hope to learn more about how RSV affects children and improve treatment.
This study looks at how the bacteria in the gut and the immune system respond in infants hospitalized with severe RSV infection. It may help doctors understand why some babies get sicker and could lead to better treatments.
Hear when a new Respiratory Complications trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.